Ara
Toplam kayıt 13, listelenen: 1-10
Management of prosthetic valve thrombosis concomitant with coronary embolism
(NLM (Medline), 2019)
We have recently read with great interest the article by Olcay (1) published in Anatol J Cardiol 2018; 20: 365-7. We appreciate the author for his report describing the concomitant left main coronary artery and mitral ...
How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis
(Springer New York LLC, 2018)
Over the last two decades, thrombolytic therapy (TT) has become an alternative to surgery as a first-line therapy in patients with thrombosed mechanical valves [1, 2, 3]. In TROIA Trial, low dose (25 mg)—slow infusion (6 ...
What is the importance of real-time three dimensional transesophageal echocardiography and time in therapeutic range in patients with prosthetic valve thrombosis?
(Springer New York LLC, 2018)
We have recently read with great interest the article reported by Cınar et al. which was published in the last issue of the Journal of Thrombosis and Thrombolysis [1]. We appreciate the authors for their report describing ...
Noninvasive diagnostic tools available for discrimination pannus from thrombus in patients with prosthetic valve dysfunction
(Blackwell Publishing Inc., 2019)
We have recently read with great interest the article by Barroso Freitas‐Ferraz et al1 entitled “Prosthetic aortic valve thrombosis: To fibrinolyse or not to fibrinolyse? That is the question!”. The authors reported a case ...
Management of antithrombotic therapy after prosthetic valve implantation
(John Wiley and Sons Inc, 2021)
To the Editor,
We have recently read with great interest the article by Wei et al. entitled “Recurrent prosthetic valve dysfunction in a patient with idiopathic hypereosinophilic syndrome: A case report and literature ...
Diagnosis, treatment & management of prosthetic valve thrombosis: the key considerations
(Taylor & Francis Ltd, 2020)
Introduction: Prosthetic heart valve thrombosis is a life-threatening complication after valve replacement surgery. Although subtherapeutic anticoagulation is the main cause, there are many other conventional and esoteric ...
Is fibrinolytic therapy really safe in the treatment of prosthetic valve thrombosis in patients with high INR?
(Wiley, 2021)
To the Editor,
We have recently read with great interest the article by Farzaneh et al.1 entitled “Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ...
Recently introduced thrombolytic therapy regimens have been sufficiently effective and safer in patients with prosthetic valve thrombosis
(Elsevier Ltd, 2019)
To the Editor, We have read with great interest the article by Araiza-Garaygordobil et al. entitled “Thrombolytic treatment for acute prosthetic valve thrombosis: Is it better than surgery?” [1]. The authors reported a ...
Identification of mechanical prosthetic heart valves based on distinctive cinefluoroscopic and echocardiographic markers
(Sage Publications Ltd, 2019)
The past 65 years have witnessed remarkable progress in the development of safe, hemodynamically favorable mechanical heart valves. Today, there are a large number and variety of prostheses in use and many prostheses have ...
Low Dose and Slow/Ultra-Slow Infusion Thrombolytic Therapy Regimens are Effective and Safe in Patients With Prosthetic Valve Thrombosis
(Elsevier Science Inc, 2020)
To the Editor,We have recently read with great interest the article by Milneet al. entitled‘Management and outcomes of prosthetic valvethrombosis. An Australian case series from the NorthernTerritory’[1].